News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeuroNova AB Prepares For Next Phase By Appointing New CEO



10/19/2005 5:12:21 PM

NeuroNova AB, a private Swedish biopharmaceutical company pioneering therapeutic neurogenesis for disorders of the central nervous system , announced today the appointment of Ulf Ljungberg, PhD, as its new President and Chief Executive Officer. Dr Ljungberg replaces Anders Haegerstrand, MD, PhD, who will assume the position of Vice President and Chief Scientific Officer within the Company. Dr Ljungberg’s appointment is effective immediately.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES